Join Mark Horoschak, Michael Fischer, and Najla Long of Bradley Arant Boult Cummings LLP for this one-hour program. The federal antitrust agencies are not cutting back on enforcement in the face of the COVID-19 pandemic. Quite the contrary, the agencies have announced a series of initiatives affecting health care providers that are highly aggressive and, in some instances, unprecedented in their nature and scope. In less than six months, the Department of Justice secured a $100 million settlement of a criminal enforcement action against a cancer center provider. The Federal Trade Commission filed suit challenging the merger of hospital systems in a major metropolitan area, alleging that the geographic market for antitrust purposes consisted of disconnected segments of that area. And the Justice Department has filed suit challenging a partial merger of hospital systems, alleging a 30% interest by one system in another suppressed competition. The federal antitrust agencies also issued a new set of Vertical Merger Guidelines, marking the first major overhaul in enforcement policy since 1984.
Our speakers have a national practice devoted to counseling health care providers on antitrust issues as well as representing such providers in federal and state antitrust investigations and in litigation. Our speakers will address the practical implications of recent antitrust initiatives for transactional attorneys and others who practice in the health care sector.